SAIBENI, SIMONE
 Distribuzione geografica
Continente #
EU - Europa 2.972
NA - Nord America 2.211
AS - Asia 1.897
SA - Sud America 187
AF - Africa 90
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.366
Nazione #
US - Stati Uniti d'America 2.128
GB - Regno Unito 1.318
CN - Cina 642
SG - Singapore 531
DE - Germania 341
IT - Italia 341
SE - Svezia 212
RU - Federazione Russa 176
VN - Vietnam 135
FR - Francia 133
BR - Brasile 131
HK - Hong Kong 131
UA - Ucraina 122
IN - India 110
IE - Irlanda 106
BD - Bangladesh 83
TR - Turchia 80
NL - Olanda 69
CA - Canada 64
CI - Costa d'Avorio 62
KR - Corea 55
JP - Giappone 53
EU - Europa 47
FI - Finlandia 46
GR - Grecia 30
CO - Colombia 24
PL - Polonia 19
AR - Argentina 17
ID - Indonesia 16
BE - Belgio 14
IQ - Iraq 13
DK - Danimarca 10
MX - Messico 8
NO - Norvegia 8
ZA - Sudafrica 7
CH - Svizzera 6
IL - Israele 6
PK - Pakistan 6
SA - Arabia Saudita 6
NZ - Nuova Zelanda 5
PH - Filippine 5
UZ - Uzbekistan 5
AT - Austria 4
EC - Ecuador 4
ES - Italia 4
TN - Tunisia 4
TW - Taiwan 4
AL - Albania 3
CL - Cile 3
EG - Egitto 3
IR - Iran 3
KE - Kenya 3
MA - Marocco 3
MY - Malesia 3
RS - Serbia 3
CR - Costa Rica 2
HR - Croazia 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
SN - Senegal 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BZ - Belize 1
CV - Capo Verde 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LY - Libia 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
Totale 7.410
Città #
Southend 1.236
Singapore 307
Ashburn 247
Chandler 188
Beijing 146
San Jose 142
Hong Kong 122
Jacksonville 114
Dublin 106
Seattle 96
Milan 89
Wilmington 88
Princeton 81
Hanover 71
Abidjan 62
Fairfield 60
Dallas 52
Redmond 51
Council Bluffs 49
Nanjing 49
Bengaluru 48
Lauterbourg 44
Los Angeles 44
Santa Clara 44
Ho Chi Minh City 41
Toronto 41
New York 39
Woodbridge 39
Ann Arbor 38
Houston 37
Mountain View 36
Dearborn 35
Frankfurt am Main 28
Buffalo 27
Des Moines 27
Hefei 27
Serra 27
Tokyo 27
Andover 26
Boardman 26
Redwood City 26
Shanghai 26
Guangzhou 24
Bogotá 23
Sakarya 23
Hanoi 22
Istanbul 21
Moscow 21
Munich 19
Phoenix 19
Grafing 18
Helsinki 18
Sunnyvale 16
São Paulo 16
Cambridge 14
Somerville 14
Warsaw 14
Berlin 13
Kiez 13
Rome 13
Shenyang 13
The Dalles 13
Tianjin 13
Jinan 12
Athens 11
Brussels 11
Cangzhou 11
Auburn Hills 9
Changsha 9
Columbus 9
Da Nang 9
Eitensheim 9
Hebei 9
Jakarta 9
Nuremberg 9
Hangzhou 8
Jiaxing 8
Kunming 8
Naples 8
Turin 8
Zhengzhou 8
Atlanta 7
Bitonto 7
Fuzhou 7
Haiphong 7
Ningbo 7
Rotterdam 7
Seoul 7
Shenzhen 7
Baghdad 6
Düsseldorf 6
Lanzhou 6
London 6
Nanchang 6
Ottawa 6
Amsterdam 5
Bühl 5
Bắc Giang 5
Falls Church 5
Fremont 5
Totale 4.751
Nome #
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease 315
Hold the Foam : Why Topical Budesonide Remains Relevant for IBD Therapy 292
Onset of inflammatory bowel disease during combined alpha-interferon and ribavirin therapy for chronic hepatitis C: report of two cases 271
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 266
Imaging of the small bowel in Crohn's disease : a review of old and new techniques 263
Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases 257
The PROSit cohort of infliximab biosimilar in IBD : a prolonged follow-up on the effectiveness and safety across Italy 253
Significance of serum Il-9 levels in inflammatory bowel disease 247
Safety and efficacy of oral, colonic-release, low molecular weight heparin-MMxTM for the treatment of mild to moderate left-sided ulcerative colitis : preliminary report of a pilot study 241
Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis : role of B12, folate, and genetics 227
B Lymphocyte intestinal homing in inflammatory bowel disease 227
Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: preliminary results of a prospective, multicenter study. 220
Safety and efficacy of oral, colonic-release, low molecular weight heparin-MmxTM for the treatment of mild to moderate left-sided ulcerative colitis : preliminary report a pilot study 217
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases 213
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients : a nationwide, prospective, 3-year follow-up study in Italy 206
Safety and efficacy of oral, colonic-release, low molecular weight heparin-MMxTM for the treatment of mild to moderate left-sided ulcerative colitis : preliminary report of a pilot study 203
Increased thrombin generation in inflammatory bowel disease 201
Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis 198
Manifestazioni tromboemboliche e rettocolite ulcerosa 195
Inflammation and coagulation in inflammatory bowel disease: the clot thickens 195
Health-related quality of life (HRQoL) assessment in patients with chronically active steroid-refractory ulcerative colitis treated by apheresis 190
Antibodies to tissue-type plasminogen activator in patients with inflammatory bowel disease 188
Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia 185
Successfull apheresis therapy in active steroid-refractory ulcerative colitis 183
Ruolo del fattore V Leiden e della mutazione G20210A PT nelle trombosi associate alle malattie infiammatorie croniche intestinali. 182
Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens 176
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar 171
Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients 169
Prevalence of human anti-transglutaminase antibodies (h-TGA) in patients with unexplained infertility and infertility with a known cause 169
Safety of treatments for inflammatory bowel disease : clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 168
MDR1 polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients 160
Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine : preliminary results of a prospective, multicenter study. 156
Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome : a comprehensive review and disease classification criteria 153
Pregnancy before and after the diagnosis of inflammatory bowel diseases : retrospective case-control study 151
Unmet needs of Italian physicians managing patients with inflammatory bowel disease 132
Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD : A Domino Effect 130
Frequenza e associazioni cliniche degli anticorpi anti citoplasma dei neutrofili. Un'esperienza locale [Frequency and clinical associations of antineutrophil cytoplasmic antibodies. A regional experience] 129
Unusual B cell morphology in inflammatory bowel disease 117
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame 84
Totale 7.700
Categoria #
all - tutte 18.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021177 0 0 0 0 0 0 0 0 0 0 139 38
2021/2022643 46 23 34 41 30 35 43 72 137 73 22 87
2022/2023636 79 62 60 76 65 122 12 35 81 11 24 9
2023/2024361 15 28 27 24 85 50 11 24 8 18 30 41
2024/2025886 43 66 14 91 74 23 28 96 54 86 88 223
2025/20261.910 215 110 184 186 190 120 216 77 244 162 206 0
Totale 7.700